|
| | ADVANCE
PROGRAM
WEDNESDAY, OCTOBER 4, 2000
|
WEDNESDAY, OCTOBER 4, 2000
|
| 08:30 - 10:15 |
Hall
A |
| PL07: |
PHARMACOTHERAPY
Chairpersons: A. Caspi, Rehovot, Israel
U. Thadani, Oklahoma City OK, USA |
| 08:30 |
PRACTICAL
IMPLICATIONS OF THERAPIES WHICH IMPROVE SURVIVAL VERSUS THERAPIES WHICH
IMPROVE SYMPTOMS IN PATIENTS WITH STABLE ANGINA PECTORIS (Invited
Lecture)
U. Thadani, Oklahoma City OK, USA |
| 08:45 |
SURPRISING
DIFFERENCES IN SPECIFIC NITRATES UPON ACCIDENTAL COADMINISTRATION OF
SILDENAFIL
E.L. Bassenge, M.
Stoeter, D. Stalleicken, B. Fink, Freiburg, Germany |
| 09:00 |
THE
ANGIOTENSIN-CONVERTING ENZYME INHIBITION POST REVASCULARIZATION STUDY
(APRES)
L. Kjoller-Hansen, R.
Steffensen, P. Grande, Copenhagen, Denmark |
| 09:15 |
BETA
BLOCKADE THERAPY: WHAT HAVE WE LEARNED FROM THE RECENT CLINICAL TRIALS
(Invited Lecture)
S. Goldstein, Detroit MI,
USA |
| 09:30 |
CURRENT
CONCEPTS REGARDING THE ROLE OF CALCIUM ANTAGONISTS IN PATIENTS WITH
CORONARY ARTERY DISEASE (Invited Lecture)
B.S. Lewis, D.A. Halon, M.Y. Flugelman, A. Merdler, N. Khader, R. Yuval,
Haifa, Israel |
| 09:45 |
PEER
REVIEW AND QUALITY IMPROVEMENT TO ACHIEVE EVIDENCE-BASED "BEST
MEDICAL PRACTICES"
N.J. Mehta, New York NY,
USA |
| 10:00 |
EFFECTS
OF THE COMBINATION OF CANDESARTAN PLUS CAPTOPRIL IN ELDERLY PATIENTS
WITH ANTERIOR MYOCARDIAL INFARCTION. A PILOT STUDY
P. Di Pasquale, S.
Cannizzaro, A. Giubilato, M.G. Vitrano, V. Bucca, G. Maringhini, S.
Scalzo, A. Tuttolomondo, A. Ortoleva, G. Follone, S. Paterna, Palermo,
Italy |
| 10:15 |
C o f f e e B r e a k |
|
WEDNESDAY, OCTOBER 4, 2000 |
| 08:30 - 10:15 |
Hall
B |
| PL08: |
BASIC MECHANISMS OF
ATHEROSCLEROSIS, VASCULAR BIOLOGY
Chairpersons: H.S. Kruth, Bethesda MD, USA
W. Maier, Zurich, Switzerland |
| 08:30 |
HARMFUL
CO-PRODUCTION OF REACTIVE OXYGEN SPECIES DURING NITROVASODILATOR THERAPY
AND EFFECTS OF ANTIOXIDANTS (Invited Lecture)
E.L. Bassenge, B. Fink,
Freiburg, Germany |
| 08:45 |
PATOCYTOSIS
- HOW HUMAN MONOCYTE-MACROPHAGES PROCESS AGGREGATED LDL (Invited
Lecture)
H.S. Kruth, W-Y. Zhang,
I. Ishii, Bethesda MD, USA |
| 09:00 |
LDL
CHOLESTEROL AND VASCULAR FUNCTION (Invited Lecture)
C. Rosendorff, New York
NY, USA |
| 09:15 |
REGULATION
OF ENDOTHELIN RECEPTORS AND FUNCTIONAL EFFECTS OF ENDOTHELIN IN HUMAN
MYOCARDIUM (Invited Lecture)
B. Pieske, Gottingen,
Germany |
| 09:30 |
ROLE
FOR AN UNCOUPLED NITRIC OXIDE SYNTHASE AS AN IMPORTANT SUPEROXIDE SOURCE
IN ATHEROSCLEROSIS (Invited Lecture)
T. Muenzel, Hamburg,
Germany |
| 09:45 |
EXPRESSION
OF HELICOBACTER PYLORI DNA IN CORONARY VESSELS OF PATIENTS WITH CORONARY
ARTERY DISEASE
W. Rees, P.C. Konturek,
M. Kowalsky, E.G. Hahn, W. Domschke, J.W. Konturek, H. Warnecke, J.
Thale, Bad Rothenfelde, Germany |
| 10:00 |
IS
VASCULAR REMODELING IN ATHEROSCLEROTIC LESIONS DETERMINED BY THE
PREEXISTING VESSEL SIZE?
R. Fuessl, H.H.
Osterhues, J. Woehrle, M. Hoeher, E. Kranenberg, U. Klausch, F.M. Baer,
H.W. Hoepp, Ulm, Germany |
| 10:15 |
INHIBITION
OF CYCLOOXYGENASE-2 DOES NOT MODIFY EARLY DEVELOPMENT OF ATHEROSCLEROSIS
IN APO-E KNOCKOUT MICE
D. Kearney, O. Belton, D.
Fitzgerald, Dublin, Ireland |
| 10:30 |
PREVALENCE
OF MICROVASCULAR DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE
(Invited Lecture)
J. Ge, J. Qian, D.
Baumgart, M. Haude, R. Erbel, Shanghai, China, Essen, Germany |
| |
C o f f e e B r e a k |
|
WEDNESDAY, OCTOBER 4, 2000 |
| 08:30 - 10:15 |
Hall
C |
| S56: |
HIBERNATION, STUNNING,
VIABILITY, SALVAGE
Chairpersons: M.D. Flather, London, UK
S. Laniado, Tel Aviv, Israel |
| 08:30 |
CARDIOPROTECTIVE
EFFECT OF THALIPORPHINE ON ISCHEMIC AND ISCHEMIC-REPERFUSION RAT HEART
L-M. Hung, S-S. Lee, M-J. Su, Taipei, Taiwan-R.O.C. |
| 08:45 |
CHRONIC
ISCHEMIC CARDIOMYOPATHY:INCREMENTAL VALUE OF THE AMOUNT OF ECHO SCAR
TISSUE AND FUNCTIONAL CLASS FOR PREDICTING CLINICAL BENEFITS OF
REVASCULARIZATION
D. Massa, G. Cataldo, G.R. Ciliberto, E. Vitali, Milan, Italy |
| 09:00 |
DO
ORAL ANTIDIABETIC DRUGS HARM THE ISCHEMIC HEART? (Invited Lecture)
R.N.A. Gasser, Graz,
Austria |
| 09:15 |
NO
SYNTHASE AND LEFT VENTRICULAR REMODELING (Invited Lecture)
W.J. Paulus, Aalst,
Belgium |
| 09:30 |
PATENCY
OF INFARCT RELATED ARTERY AND LEVELS OF D-DIMERS AFTER THROMBOLYSIS FOR
ACUTE MYOCARDIAL INFARCTION
N. Kafkas, P. Lianidou,
T. Lyras, V. Papanagiotou, G. Merzanos, K. Kardassilari, K. Kelesidis,
Athens, Greece |
| 09:45 |
EFFECTIVENESS
OF IIB-IIIA GLYCOPROTEIN RECEPTORS INHIBITORS IN PATIENTS WITH AMI AND
FAILED THROMBOLYSIS
P. Di Pasquale, S.
Cannizzaro, A. Giubilato, M.G. Vitrano, F. Giambanco, A. Pinto, A.
Tuttolomondo, A. Ortoleva, G. Saccone, S. Paterna, Palermo, Italy |
| 10:00 |
PRELIMINARY
APPLICATION OF EXTERNAL THERAPEUTIC ULTRASOUND ACCELERATING THROMBOLYSIS
IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
J. Bai, X. Shen, N. Cai,
Shanghai, China |
| 10:15 |
C o f f e e B r e a k |
|
WEDNESDAY, OCTOBER 4, 2000 |
| 10:45 - 12:30 |
Hall
A |
| PL09: |
INTERVENTIONAL CARDIOLOGY IN THE NEW MILLENIUM : IS
SMALLER BETTER?
Supported by Medtronic AVE
Chairpersons: B. Chevalier, Saint-Denis, France
M. Witkowska, Wroclaw, Poland |
| |
SMALL VESSEL
STENTING
SMALL VESSEL
STENTING: EXPERIENCE FROM THE POLISH MULTICENTER REGISTRY AND ICARUS I
& II STUDIES
A. Witkowski, Warsaw, Poland
THE STENTING IN SMALL ARTERIES STUDY : 6-MONTH QUANTITATIVE ANGIOGRAPHY
RESULTS
M. Schalij, Leiden, The Netherlands
FINAL RESULTS OF THE BESMART STUDY
M. Gilard, Brest, France
WHAT CAN WE CONCLUDE ABOUT SMALL VESSEL STENTING?
B. Chevalier, Saint-Denis, France |
| |
MINIMIZED
INTERVENTIONS
MINIMALLY INVASIVE FEMORAL APPROACH USING 5F GUIDING CATHETER
B. Chevalier, Saint-Denis, France
RADIAL APPROACH ANGIOPLASTY WITH 5F GUIDING CATHETER
Y.R. Louvard, Massy, France |
| 12:30 |
L u n c h B r e a k |
| |
|
WEDNESDAY, OCTOBER 4, 2000 |
| 10:45 - 12:30 |
Hall
B |
| PL10: |
ANGIOGENESIS AND GENE THERAPY
Chairpersons: H.K. Hammond, La Jolla CA, USA
R.J. Laham, Boston MA, USA |
| 10:45 |
THERAPEUTIC
ANGIOGENESIS - PITFALLS AND PROMISES (Invited Lecture)
R.J. Laham, Boston MA, USA |
| 11:00 |
GENE
THERAPY USING ANGIOGENIC GENE FOR MYOCARDIAL ISCHEMIA (Invited Lecture)
H.K. Hammond, San Diego CA, USA |
| 11:15 |
VECTORS
AND DELIVERY SYSTEMS FOR CARDIOVASCULAR GENE THERAPY (Invited Lecture)
M.Y. Flugelman, Haifa, Israel |
| 11:30 |
USE
OF ANGIOGENIC THERAPY IN CARDIO-VASCULAR DISEASES (Invited Lecture)
N.N. Kipshidze, K.
Kipiani, N. Beridze, N. Kipshidze, Tblisi, Georgia |
| 11:45 |
PERIVASCULAR
ENDOTHELIAL CELL TRANSPLANTATION
H.M. Nugent, M.A. Nugent,
E.R. Edelman, Boston MA, USA |
| 12:00 |
GENE
THERAPY USING ADENYLATE CYCLASE FOR HEART FAILURE
H. Kirk Hammond, San
Diego CA, USA |
| 12:15 |
A
STRONG ENHANCEMENT OF IN VIVO GENE TRANSFER INTO THE ISCHEMIC SKELETAL
MUSCLE IN THE RAT BY PULSED ELECTRIC FIELDS
N.B. Dev, J. Primavera,
S. Bleecher, G. Widera, D.P. Rabussay, San Diego, CA, USA |
| 12:30 |
ENHANCED
EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR DURING ANGIOGENESIS AND
HEALING IN INFARCTED MYOCARDIUM
E. Takase, A. Morimoto,
Y. Kuga, H. Ozaki, Osaka, Japan |
| 12:45 |
L u n c h B r e a k |
|
WEDNESDAY, OCTOBER 4, 2000 |
| 10:45 - 12:30 |
Hall
C |
| S57: |
SURGICAL ASPECTS
Chairpersons: B.S. Goldman, Toronto ON, Canada
J.F. Obadia, Lyon, France |
| 10:45 |
TRENDS
IN CORONARY ARTERY BYPASS SURGERY (Invited Lecture)
B.S. Goldman, D. Abramov,
M. Tamariz, S.E. Fremes, G.T. Christakis, G. Bhatnagar, V. Guru,
Toronto, Canada |
| 11:00 |
MYOCARDIAL
REVASCULARIZATION WITHOUT CARDIOPULMONARY BYPASS (Invited Lecture)
A.M. Calafiore, Chieti,
Italy |
| 11:15 |
QUALITY
CONTROL IN CORONARY ARTERY BYPASS SURGERY. HOSPITAL MORTALITY AND
MORBIDITY UNDERESTIMATES THE REALITY
L. Noyez, F.W.A.
Verheugt, N. Peppelenbosch, S.H. Skotnicki, R.M.H.J. Brouwer, Nijmegen,
The Netherlands |
| 11:30 |
SIGNIFICANT
IMPROVEMENT OF EARLY MUSCULAR RESPIRATORY DRIVE AFTER CHEST CLOSURE WITH
THE REINFORCED STERNAL CLOSURE SYSTEM
S. Saenger, H.R.
Zurbrugg, M. Bauer, M. Musci, R. Ewert, T. Freestone, E. Terzi, J.
Knorig, R. Hetzer, Berlin, Germany |
| 11:45 |
THE
OUTCOME OF EMERGENT CORONARY ARTERY BYPASS GRAFTING IN 6 HOURS AFTER
ACUTE MYOCARDIAL INFARCTION
M. Tobe, J. Kondo, K.
Imoto, S. Suzuki, S. Isoda, K. Kimura, Y. Takanashi, Yokohama City,
Japan |
| 12:00 |
DOES
CORONARY ENDARTERECTOMY INCREASE THE RISK OF CORONARY BYPASS?
S. Silberman, I.
Dzigivker, O. Merin, N. Shapira, N. Hamudi, G. Falkowski, D. Bitran,
Jerusalem, Israel |
| 12:15 |
OPERATIVE
MORTALITY FOLLOWING FIRST TIME CORONARY BYPASS GRAFTING IN INDIAN
SUBCONTINENT ASIANS AND CAUCASIANS IN UK AND WALES
D. Zindrou, J. Peder
Bagger, P. Smith, K. Taylor, C. Ratnatunga, London, UK |
| 12:30 |
INFLUENCE
OF HYBRID VASCULAR MESH PROSTHESIS USE ON DEGENERATIVE PROCESSES IN VEIN
GRAFTS
M. Krejca, J. Skarysz, A.
Bochenek, Katowice, Poland |
| 12:45 |
INHIBITORY
EFFECT OF METHYLENE BLUE-INDUCED PHOTOOXIDATION ON INTIMAL THICKENING OF
VEIN GRAFT
K-X. Liu, F. Yamamoto, S.
Sekine, Y. Goto, K. Seki, K. Kondoh, Akita, Japan |
| 13:00 |
L u n c h B r e a k |
|
WEDNESDAY, OCTOBER 4, 2000 |
| 14:00 - 17:30 |
Hall
A |
| SA03: |
Satellite Symposium
VASCULAR BRACHYTHERAPY: STATE OF THE ART
Sponsored by an
unrestricted educational grant from Guidant & Novoste Corporations
Chairpersons: B. Chevalier, Saint-Denis, France
R. Waksman, Washington DC, USA
PROBLEM OF
RESTENOSIS/VBT OBJECTIVES
B. Chevalier, Saint-Denis, France
DOSIMETRY IN VASCULAR BRACHYTHERAPY
W. Dries, The Netherlands
GUIDANT'S RADIATION THERAPY CLINICAL DATA AND PRESENTATION OF THE
GALILEO SYSTEM
E. Mac Fadden
AVAILABLE TECHNOLOGY (PRODUCT, CLINICAL TRIAL UPDATE AND CASE EXAMPLES)
M. Joyal, Canada COST/BENEFIT OF VBT
B. van Hout, The Netherlands Debate:
INDICATIONS: ISR vs DE NOVO D. Meerkin, Israel
S. Silber, Germany Debate:
PROMISING THERAPY vs. ALTERNATIVE TECHNOLOGIES R. Waksman, USA
T. Gershlick, UK PANEL DISCUSSION - ALL SPEAKERS |
|
WEDNESDAY, OCTOBER 4, 2000 |
| 14:00 - 15:30 |
Hall
B |
| S59: |
CLINICAL ASPECTS
Chairpersons: M.S. Gotsman, Jerusalem, Israel
L. Reisin, Ashkelon, Israel |
| 14:00 |
CRITICAL
PATHAWAYS FOR THE EVALUATION OF CHEST PAIN (Invited Lecture)
E. Bonnefoy, Lyon, France |
| 14:15 |
SELECTION
OF PATIENTS FOR REVASCULARIZATION: MEDICAL AND NON-MEDICAL ASPECTS
(Invited Lecture)
M. Keltai, Budapest,
Hungary |
| 14:30 |
NONINVASIVE
PREDICTORS OF CARDIAC MORTALITY IN ACUTE MYOCARDIAL INFARCTION
G. Kazianis, S. Feggos,
A. Gournizakis, M. Karpathiotakis, A. Economou,
Athens, Greece |
| 14:45 |
ISCHEMIC
HEART DISEASE IN POST-MENOPAUSAL WOMEN: A SUBSET OF PATIENTS DESERVING A
SPECIFIC APPROACH (Invited Lecture)
B. Rabinowitz, Tel
Hashomer, Israel |
| 15:00 |
CHLAMYDIA
PNEUMONIAE INFECTION AND CORONARY ARTERY DISEASE
(Invited Lecture)
W. Maier, Bern,
Switzerland |
| 15:15 |
DIABETES
INCREASES THE EARLY MORTALITY RISK OF PATIENTS WITH ACUTE MI
PARTICULARLY IN YOUNGER AGE-GROUPS
H. Gilutz, R. Ilia, J.
Leor, V. Boyko, S. Behar, Beer Sheva, Israel |
| 15:30 |
REDUCTION
IN MORTALITY IN AMI AMONG WOMEN IN THE '90's: INTENSIVE CARDIAC CARE
UNIT VS. INTERNAL MEDICINE WARD
Z. Rotstein, A.
Gottesmann, B. Lavi, H. Hod, Tel Hashomer, Israel |
| 15:45 |
C o f f e e B r e a k |
|
WEDNESDAY, OCTOBER 4, 2000 |
| 14:00 - 15:30 |
Hall
C |
| S61: |
ACUTE CORONARY SYNDROMES
Chairpersons: R. Diaz, Rosario, Argentina
R.N.A. Gasser, Graz, Austria |
| 14:00 |
NATURAL
HISTORY OF ACUTE CORONARY SYNDROMES (Invited Lecture)
S.N. Willich, Berlin,
Germany |
| 14:15 |
PRACTICE
PATTERNS AND OUTCOMES FOR ACUTE CORONARY SYNDROMES (Invited Lecture)
M.D. Flather, London, UK |
| 14:30 |
HEART
FAILURE AFTER ACUTE CORONARY SYNDROMES: INCIDENCE AND PROGNOSIS IN THE
PROSPECTIVE REGISTRY OF ACUTE ISCHEMIC SYNDROMES IN THE UNITED KINGDOM
(PRAIS-UK)
M. Shibata, J.R.
Collinson, A. Bakhai, M.D. Flather, R. Mattu, P. Ludman, K.A.A. Fox,
London, UK |
| 14:45 |
MANAGEMENT
OF ACUTE CORONARY SYNDROMES WITHOUT ST ELEVATION. STATE OF THE ART
(Invited Lecture)
E. Paolasso, Rosario,
Argentina |
| 15:00 |
EARLY
COURSE OF ACUTE PHASE REACTANTS IN ACUTE CORONARY SYNDROMES
M. Aydin, M. Tokac, M.
Yazici, G. Danis, E. Yeter, K. Ozdemir,
H. Gok, Konya, Turkey |
| 15:15 |
CIRCULATING
LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN ACUTE CORONARY SYNDROME
A.Z. Darwish, N.M. Bader
El Dean, S.F. Hammoudah, Tanta, Egypt |
| 15:30 |
C o f f e e B r e a k |
|
WEDNESDAY, OCTOBER 4, 2000 |
| 16:00 - 17:30 |
Hall
B |
| S58: |
PHARMACOTHERAPY
Chairpersons: B. Rabinowitz, Tel Hashomer, Israel
U. Thadani, Oklahoma City OK, USA |
| 16:00 |
THE
EFFECT OF SHORT TERM ATORVASTATIN TREATMENT ON FIBRINOLYTIC SYSTEM IN
PATIENTS WITH HYPERLIPIDEMIC CORONARY HEART DISEASE
E. Atalar, T. Acil, K. Aytemir, A. Daver, N. Ozer, I. Haznedaroglu, K.
Ovunc, S. Aksoyek, S. Kes, F.O Hacettep, Ankara, Turkey |
| 16:15 |
PHARMACODYNAMIC
INTERACTION BETWEEN THE SELECTIVE CHOLESTEROL ABSORPTION INHIBITOR
EZETIMIBE AND LOVASTATIN
T. Kosoglou, I. Meyer, D.L. Cutler, B. Musiol, B. Yang, Y. Zhu, S.E.
Maxwell, M.B. Affrime, E.P. Veltri, Kenilworth NJ, USA |
| 16:30 |
ASPIRIN
50MG DAILY FOR THE PREVENTION OF CARDIAC EVENTS AFTER MYOCARDIAL
INFARCTION
T. Watanabe, A. Kimura, N. Takeda, H. Furuta, N. Naito, A. Ikeda, H. Ino,
Osaka, Japan |
| 16:45 |
ANTIPLATELET
TREATMENT WITH CILOSTAZOL AFTER STENT IMPLANTATION
K. Tanaka, Y. Yoshitomi,
S. Kojima, M. Yano, T. Sugi, Y. Matsumoto, M. Endo, Shizuoka, Japan |
| 17:00 |
EFFECT
OF BETA-BLOCKERS ON CARDIAC EVENTS IN PATIENTS WITH HEALED MYOCARDIAL
INFARCTION
N. Takeda, A. Kimura, T.
Watanabe, H. Furuta, H. Ino, T. Taniwa, H. Yabushita, Osaka, Japan |
| 17:15 |
ABCIXIMAB
USED AS "BAIL-OUT DRUG" IS SAFE AT LOWER COST COMPARED TO THE
RECOMMENDED PRETREATMENT IN HIGH RISK ANGIOPLASTY
I. Kugler, M. Homdasch,
O. Franz, W. Bauer, W. Voelker, J. Schoenberger, T. Poemer, G. Ertl, P.
Gaudron, Mannheim, Germany |
| 17:30 |
STATE
OF PLATELET HAEMOSTASIS UNDER MODERATE DOSE OF ASPIRIN TREATMENT IN
PATIENTS WITH DIFFERENT ACUTE CORONARY SYNDROMES PRESENTATIONS
O. Dotsenko, Kiev,
Ukraine |
| 17:45 |
THE
EFFECT OF BETA-BLOCKERS ON VENTRICULAR LATE POTENTIALS IN PATIENTS WITH
ACUTE ANTERIOR MYOCARDIAL INFARCTION RECEIVING THROMBOLYTIC THERAPY
H. Evrengul, M.
Kayikcioglu, L. Can, S. Payzin, H. Kultursay, M. Akin, C. Turkoglu,
Izmir, Turkey |
|
WEDNESDAY, OCTOBER 4, 2000 |
| 16:00 - 17:30 |
Hall
C |
| S60: |
ATHEROSCLEROSIS
Chairpersons: O. Abdel-Aziz, Cairo, Egypt
H.S. Kruth, Bethesda MD, USA |
| 16:00 |
ACTIVATED
LEUKOCYTES AND MONOCYTES IN THE PERIPHERAL BLOOD CORRESPOND TO THE
PRESENCE OF MULTIPLE RISK FACTORS FOR ATHEROSCLEROSIS
I. Shapira, D. Seltzer,
O. Rogowski, R. Rotstein, R. Fusman, V. Prochorov, A. Roth, N.
Bornstein, G. Keren, A. Eldor, S. Berliner, Tel Aviv, Israel |
| 16:15 |
NON-LIPID
EFFECTS OF STATIN IN HYPERCHOLESTEROLEMIC PATIENTS WITH ESTABLISHED
CORONARY ARTERY DISEASE REFRACTORY TO STEP II DIET
K.K. Koh, J.W. Son, D.
Jin, J.Y. Ahn, M.S. Sohn, T-H. Ahn, S. Choi, Inchon, South Korea |
| 16:30 |
EVALUATION
OF THE EFFECT OF ESTROGEN ON OVARIECTOMISED JAPANESE MONKEYS BY
ANGIOSCOPY
N. Ikeda, R. Torii,
Shiga, Japan |
| 16:45 |
PREVIOUS
MICROBIAL INFECTIONS IN A COMMUNITY BASED CASE-CONTROL STUDY OF CORONARY
HEART DISEASE
R. Mak, L. Van
Renterghem, D. De Bacquer, G. De Backer, M. Kornitzer, Gent, Belgium |
| 17:00 |
FUNCTIONAL
POLYMORPHISM IN MATRIX METALLOPROTEINASE-9 GENE ASSOCATED WITH CORONARY
ATHEROSCLEROSIS
B. Zhang, S. Ye, S.
Herrmann, P. Eriksson, M. de Maat, A. Evans, D. Arveiler, G. Luc, F.
Cambien, A. Hamsten, H. Watkins, A. Henney, Oxford, UK |
| 17:15 |
INCREASED
AUTOANTIBODY TITERS AGAINST OXIDIZED LDL ARE NOT MARKER OF
ATHEROSCLEROSIS
S. Koulouris, I.
Karabinos, A. Melpidou, G. Makris, I. Moshovitis, N. Papageorgakis, T.
Gianoulis, A. Kranidis, F. Symeonidis, A. Paraskevopoulos, Z. Zoulien,
N. Exadaktylos, Athens, Greece |
| 17:30 |
MAST
CELLS OF AORTAL INTIMA IN EARLY ATHEROSCLEROTIC LESIONS
V. Zhdanov, N. Sternby,
I. Drobkova, N. Cherpachenko, I. Galakhov, Moscow, Russia |
|
